Moreover, based on our current database of RNA-seq, our results suggested that other oxidative-related genes, such as YPEL2 and HSPA2 could become promising treatment targets in dry eye after systematic in vitro and in vivo studies. This evidence concerns the gene HSPA2 and dry eye syndrome.